ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

ClinicalTrials.gov ID: NCT00139776

Public ClinicalTrials.gov record NCT00139776. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind Parallel-Group Randomized Study Of Efficacy And Safety Of "Continuous Use" Of Celecoxib Vs. The "Usual Use" Of Celecoxib In The Treatment Of Subjects With Chronic Osteoarthritis Of The Hip Or Knee Who Require an Anti-inflammatory Medication for Control Of Their Pain

Study identification

NCT ID
NCT00139776
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
875 participants

Conditions and interventions

Interventions

  • Celecoxib Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2005
Primary completion
Jan 31, 2008
Completion
Jan 31, 2008
Last update posted
Mar 28, 2021

2005 – 2008

United States locations

U.S. sites
67
U.S. states
25
U.S. cities
61
Facility City State ZIP Site status
Pfizer Investigational Site Huntsville Alabama 35801
Pfizer Investigational Site Peoria Arizona 85381
Pfizer Investigational Site Phoenix Arizona 85051
Pfizer Investigational Site Anaheim California 92801
Pfizer Investigational Site Huntington Beach California 92646
Pfizer Investigational Site Long Beach California 90806
Pfizer Investigational Site Orange California 92868
Pfizer Investigational Site Paramount California 90723
Pfizer Investigational Site Stockton California 95204
Pfizer Investigational Site Tustin California 92780
Pfizer Investigational Site Walnut Creek California 94598
Pfizer Investigational Site Whittier California 90601
Pfizer Investigational Site Wheat Ridge Colorado 80033
Pfizer Investigational Site Danbury Connecticut 06810
Pfizer Investigational Site New Milford Connecticut 06776
Pfizer Investigational Site Waterbury Connecticut 06708
Pfizer Investigational Site Ocala Florida 34474
Pfizer Investigational Site Palm Harbor Florida 34684
Pfizer Investigational Site South Miami Florida 33143
Pfizer Investigational Site Tampa Florida 33614-7118
Pfizer Investigational Site Zephyrhills Florida 33542
Pfizer Investigational Site Decatur Georgia 30033
Pfizer Investigational Site Springfield Illinois 62704
Pfizer Investigational Site Dubuque Iowa 52001-7313
Pfizer Investigational Site Dubuque Iowa 52002
Pfizer Investigational Site Lexington Kentucky 40509
Pfizer Investigational Site Madisonville Kentucky 42431
Pfizer Investigational Site Baltimore Maryland 21218
Pfizer Investigational Site Clinton Maryland 20735
Pfizer Investigational Site Frederick Maryland 21702
Pfizer Investigational Site Greenbelt Maryland 20770
Pfizer Investigational Site Wheaton Maryland 20902
Pfizer Investigational Site Brockton Massachusetts 02301
Pfizer Investigational Site Jefferson City Missouri 65101
Pfizer Investigational Site Jefferson City Missouri 65109
Pfizer Investigational Site Springfield Missouri 65807
Pfizer Investigational Site Lincoln Nebraska 68516
Pfizer Investigational Site Omaha Nebraska 68134
Pfizer Investigational Site Las Vegas Nevada 89106
Pfizer Investigational Site Las Vegas Nevada 89144
Pfizer Investigational Site Great Neck New York 11021
Pfizer Investigational Site Manlius New York 13104
Pfizer Investigational Site Mineola New York 11501
Pfizer Investigational Site New York New York 10022-1009
Pfizer Investigational Site Rochester New York 14609
Pfizer Investigational Site Winston-Salem North Carolina 27103-4019
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Cleveland Ohio 44122
Pfizer Investigational Site Columbus Ohio 43210-1228
Pfizer Investigational Site Zanesville Ohio 43701
Pfizer Investigational Site Eugene Oregon 97401
Pfizer Investigational Site Beaver Pennsylvania 15009
Pfizer Investigational Site Camp Hill Pennsylvania 17011
Pfizer Investigational Site Duncansville Pennsylvania 16635-0909
Pfizer Investigational Site Johnstown Pennsylvania 15904
Pfizer Investigational Site Philadelphia Pennsylvania 19152
Pfizer Investigational Site Johnson City Tennessee 37601
Pfizer Investigational Site Knoxville Tennessee 37920
Pfizer Investigational Site New Tazewell Tennessee 37825
Pfizer Investigational Site Dallas Texas 75231
Pfizer Investigational Site Dallas Texas 75235
Pfizer Investigational Site Arlington Virginia 22205
Pfizer Investigational Site Renton Washington 98055
Pfizer Investigational Site Tacoma Washington 98405
Pfizer Investigational Site Yakima Washington 98902-4876
Pfizer Investigational Site Yakima Washington 98902
Pfizer Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00139776, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2021 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00139776 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →